https://www.simsrx.consulting/hospice-medication-executive-development-h-med2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/blog-medicine-minds2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/methadone-for-pain-pearls-practical-insights-for-serious-illness-and-hospice-care2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/executive-advisory2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/addiction-medicine-in-serious-illness-introduction2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/product-advisory2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/medication-transparency-in-pharmacy-benefits2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/pbm-reform-is-now-law-but-hospice-still-needs-a-seat-at-the-table2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/addiction-medicine-in-serious-illness-chapter2-xylazine-medetomidine-tranq-and-the-complex-sedative-crisis-within-the-fentanyl-epidemic2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/addiction-medicine-in-serious-illness-chapter-1-traditional-initiation-therapies-for-moud-methadone-vs-buprenorphine2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/open-vs-closed-medication-formularies-in-hospice-finding-the-right-balance2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/leadership2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/vendor-relations2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting2026-05-12T03:08:51.000Z1.0https://www.simsrx.consulting/education-and-expert-witness2026-05-12T03:08:51.000Z0.5https://www.simsrx.consulting/clinical-pharmacy-consulting2026-05-12T03:08:51.000Z0.5